Pages that link to "Q56582915"
Jump to navigation
Jump to search
The following pages link to University of Utah Health Care (Q56582915):
Displayed 50 items.
- University of Utah (Q168515) (← links)
- Harper Lee (Q182658) (← links)
- Edward T. Nelson (Q37838460) (← links)
- Keng-Min Lin (Q39476018) (← links)
- Zachary M. Working (Q41610448) (← links)
- Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort (Q45272012) (← links)
- Polina V. Kukhareva (Q47325895) (← links)
- John F Hurdle (Q47818566) (← links)
- Dennis Nielson (Q55241034) (← links)
- Martha Monson (Q56452155) (← links)
- Stephen J Fenton (Q57016601) (← links)
- Scott A Larson (Q57050743) (← links)
- Donald Dudley (Q57441116) (← links)
- Mark Harris (Q57863157) (← links)
- Jessica M Louie (Q58358992) (← links)
- Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer (Q58407403) (← links)
- Kalani L Raphael (Q58821873) (← links)
- A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma (Q58845806) (← links)
- Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy (Q58848980) (← links)
- Albert Salas-Huetos (Q59207957) (← links)
- Kathleen Campbell (Q59661704) (← links)
- Joshua Klatt (Q59917077) (← links)
- Henrik Odéen (Q61167141) (← links)
- A Randomized Trial of Induction Versus Expectant Management (Q61864782) (← links)
- A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (Q61894391) (← links)
- Propranolol in Treating Hypoglycemia Unawareness (Q61909150) (← links)
- An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors (Q61909650) (← links)
- Clinical Outcomes Following Glenoid Neck Fracture as Correlated With Quantitative Assessment of Osseous Injury (Q61914489) (← links)
- Anemia in the Elderly (Q61914869) (← links)
- Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD (Q61914922) (← links)
- Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa (Q61915132) (← links)
- Safety of Sports for Patients With Implantable Cardioverter-Defibrillators (Q61915202) (← links)
- Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin) (Q61915462) (← links)
- Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria (Q61915488) (← links)
- A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas (Q61915528) (← links)
- Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism (Q61915563) (← links)
- Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation (Q61917851) (← links)
- VentrAssistTM LVAD for the Treatment of Advanced Heart Failure - Destination Therapy (Q61918066) (← links)
- A Study of Flovent in Patients With Eosinophilic Esophagitis (Q61921444) (← links)
- A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa (Q61924249) (← links)
- A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa (Q61924250) (← links)
- A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration (Q61924253) (← links)
- Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis (Q61924872) (← links)
- Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular Atrophy (Q61932645) (← links)
- Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease (Q61934429) (← links)
- MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer (Q61936425) (← links)
- Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP) (Q61936481) (← links)
- Acitretin or Tazarotene Gel and Excimer Laser for Treatment of Psoriasis (Q61936743) (← links)
- A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE) (Q61938291) (← links)
- Feasibility Study of BMAC Enhanced CABG (Q61938387) (← links)